These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 12149529

  • 1. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.
    Verhoeven GT, Hegmans JP, Mulder PG, Bogaard JM, Hoogsteden HC, Prins JB.
    Thorax; 2002 Aug; 57(8):694-700. PubMed ID: 12149529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.
    Eur J Gen Pract; 2007 Aug; 13(2):89-91. PubMed ID: 17534745
    [Abstract] [Full Text] [Related]

  • 7. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
    Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC.
    Am J Respir Crit Care Med; 2002 Jun 15; 165(12):1592-6. PubMed ID: 12070058
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 15; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 9. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
    Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R, Hamid Q.
    Thorax; 2007 Nov 15; 62(11):938-43. PubMed ID: 17557771
    [Abstract] [Full Text] [Related]

  • 10. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
    Spicuzza L, Scuderi V, Morjaria JB, Prosperini G, Arcidiacono G, Caruso M, Folisi C, Di Maria GU, Polosa R.
    Pulm Pharmacol Ther; 2014 Feb 15; 27(1):70-5. PubMed ID: 23688422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
    Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Apr 15; 88(4):401-9. PubMed ID: 11991558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial.
    Ayres JG, Price MJ, Efthimiou J.
    Respir Med; 2003 Mar 15; 97(3):212-20. PubMed ID: 12645827
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May 15; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.